DK164547C - Imidazoliumsalte til brug ved saenkning af blodsukkerniveauet hos pattedyr og farmaceutiske praeparater indeholdende saadanne salte - Google Patents
Imidazoliumsalte til brug ved saenkning af blodsukkerniveauet hos pattedyr og farmaceutiske praeparater indeholdende saadanne salteInfo
- Publication number
- DK164547C DK164547C DK515285A DK515285A DK164547C DK 164547 C DK164547 C DK 164547C DK 515285 A DK515285 A DK 515285A DK 515285 A DK515285 A DK 515285A DK 164547 C DK164547 C DK 164547C
- Authority
- DK
- Denmark
- Prior art keywords
- salts
- mammals
- blood sugar
- pharmaceutical preparations
- sugar level
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 title 1
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 150000004693 imidazolium salts Chemical class 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/670,776 US4609670A (en) | 1984-11-13 | 1984-11-13 | Imidazolium hypoglycemic agents |
US67077684 | 1984-11-13 |
Publications (4)
Publication Number | Publication Date |
---|---|
DK515285D0 DK515285D0 (da) | 1985-11-08 |
DK515285A DK515285A (da) | 1986-05-14 |
DK164547B DK164547B (da) | 1992-07-13 |
DK164547C true DK164547C (da) | 1992-11-30 |
Family
ID=24691822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK515285A DK164547C (da) | 1984-11-13 | 1985-11-08 | Imidazoliumsalte til brug ved saenkning af blodsukkerniveauet hos pattedyr og farmaceutiske praeparater indeholdende saadanne salte |
Country Status (21)
Country | Link |
---|---|
US (1) | US4609670A (da) |
EP (1) | EP0182533B1 (da) |
JP (1) | JPH0647576B2 (da) |
KR (1) | KR880001231B1 (da) |
CN (1) | CN1013444B (da) |
AR (1) | AR244671A1 (da) |
AT (1) | ATE46505T1 (da) |
AU (1) | AU574532B2 (da) |
CA (1) | CA1266673A (da) |
DE (1) | DE3573114D1 (da) |
DK (1) | DK164547C (da) |
EG (1) | EG17707A (da) |
ES (1) | ES8702370A1 (da) |
GR (1) | GR852707B (da) |
HU (1) | HU195490B (da) |
IE (1) | IE59093B1 (da) |
NZ (1) | NZ214088A (da) |
PH (1) | PH21656A (da) |
PT (1) | PT81439B (da) |
SU (1) | SU1424733A3 (da) |
ZA (1) | ZA858499B (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5656261A (en) * | 1995-01-18 | 1997-08-12 | The Picower Institute For Medical Research | Preventing and reversing advanced glycosylation endproducts |
FI119756B (fi) | 1995-01-18 | 2009-03-13 | Alteon Inc | Tiatsoliumyhdisteiden käyttö pitkälle edenneen glykosylaation lopputuotteiden muodostumisen estossa ja suunnan muutoksessa |
EP1327887A3 (en) * | 1995-01-18 | 2008-12-10 | Synvista Therapeutics, Inc. | Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation end products |
US20040198795A1 (en) * | 1996-05-08 | 2004-10-07 | Wagle Dilip R | Substituted imidazoliums and methods of use therefor |
US6121300A (en) | 1998-11-10 | 2000-09-19 | Wagle; Dilip R. | Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts |
US6781039B2 (en) * | 2002-05-07 | 2004-08-24 | Stine Seed Farm, Inc. | Soybean cultivar S010360 |
DE102006028264B4 (de) * | 2006-01-10 | 2008-12-11 | Uwe Pisching | Sägebock |
CN100460395C (zh) * | 2006-07-06 | 2009-02-11 | 云南大学 | 芳环和杂环酰甲基咪唑盐类化合物及其制备方法 |
WO2011109059A1 (en) * | 2010-03-01 | 2011-09-09 | Gtx, Inc. | Compounds for treatment of cancer |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3852301A (en) * | 1973-06-21 | 1974-12-03 | Squibb & Sons Inc | Enol betaines of imidazoles |
US4017631A (en) * | 1974-11-19 | 1977-04-12 | Janssen Pharmaceutica N.V. | Imidazolium salts |
GB1533706A (en) * | 1976-03-01 | 1978-11-29 | Ici Ltd | Fungicidal imidazoles and 1,2,4-triazoles |
DE2643563A1 (de) * | 1976-09-28 | 1978-03-30 | Bayer Ag | Alpha-(4-biphenylyl)-benzyl-azolium- salze, verfahren zu ihrer herstellung sowie ihre verwendung zur bekaempfung von mikroorganismen |
DE2714290A1 (de) * | 1977-03-31 | 1978-10-05 | Bayer Ag | Fungizide mittel |
JPS5479278A (en) * | 1977-12-05 | 1979-06-25 | Nippon Soda Co Ltd | Imidazolium halide |
JPS58150567A (ja) * | 1982-03-03 | 1983-09-07 | Kissei Pharmaceut Co Ltd | 新規な1,3−二置換イミダゾ−ル誘導体およびその製造方法 |
US4581370A (en) * | 1983-07-12 | 1986-04-08 | Schering A.G. | Antiarrhythmic imidazoliums |
-
1984
- 1984-11-13 US US06/670,776 patent/US4609670A/en not_active Expired - Fee Related
-
1985
- 1985-11-05 ZA ZA858499A patent/ZA858499B/xx unknown
- 1985-11-05 AR AR85302178A patent/AR244671A1/es active
- 1985-11-05 AT AT85308017T patent/ATE46505T1/de not_active IP Right Cessation
- 1985-11-05 DE DE8585308017T patent/DE3573114D1/de not_active Expired
- 1985-11-05 EP EP85308017A patent/EP0182533B1/en not_active Expired
- 1985-11-05 CN CN85108115A patent/CN1013444B/zh not_active Expired
- 1985-11-06 PT PT81439A patent/PT81439B/pt not_active IP Right Cessation
- 1985-11-06 CA CA000494704A patent/CA1266673A/en not_active Expired - Lifetime
- 1985-11-06 NZ NZ214088A patent/NZ214088A/xx unknown
- 1985-11-08 KR KR1019850008349A patent/KR880001231B1/ko not_active IP Right Cessation
- 1985-11-08 DK DK515285A patent/DK164547C/da not_active IP Right Cessation
- 1985-11-08 PH PH33043A patent/PH21656A/en unknown
- 1985-11-08 GR GR852707A patent/GR852707B/el unknown
- 1985-11-11 SU SU853972626A patent/SU1424733A3/ru active
- 1985-11-11 AU AU49737/85A patent/AU574532B2/en not_active Ceased
- 1985-11-12 IE IE282285A patent/IE59093B1/en not_active IP Right Cessation
- 1985-11-12 EG EG722/85A patent/EG17707A/xx active
- 1985-11-12 JP JP60254599A patent/JPH0647576B2/ja not_active Expired - Lifetime
- 1985-11-12 ES ES548797A patent/ES8702370A1/es not_active Expired
- 1985-11-12 HU HU854325A patent/HU195490B/hu not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA1266673A (en) | 1990-03-13 |
CN1013444B (zh) | 1991-08-07 |
HU195490B (en) | 1988-05-30 |
DK164547B (da) | 1992-07-13 |
AR244671A1 (es) | 1993-11-30 |
ES548797A0 (es) | 1987-01-01 |
JPS61122212A (ja) | 1986-06-10 |
GR852707B (da) | 1986-03-10 |
PT81439A (en) | 1985-12-01 |
DE3573114D1 (en) | 1989-10-26 |
PT81439B (pt) | 1988-03-03 |
US4609670A (en) | 1986-09-02 |
IE59093B1 (en) | 1994-01-12 |
CN85108115A (zh) | 1986-07-30 |
EP0182533B1 (en) | 1989-09-20 |
SU1424733A3 (ru) | 1988-09-15 |
JPH0647576B2 (ja) | 1994-06-22 |
DK515285D0 (da) | 1985-11-08 |
EG17707A (en) | 1990-08-30 |
EP0182533A3 (en) | 1987-06-03 |
ZA858499B (en) | 1987-06-24 |
AU4973785A (en) | 1986-05-22 |
KR880001231B1 (ko) | 1988-07-12 |
PH21656A (en) | 1988-01-13 |
KR860004029A (ko) | 1986-06-16 |
ATE46505T1 (de) | 1989-10-15 |
HUT39164A (en) | 1986-08-28 |
DK515285A (da) | 1986-05-14 |
ES8702370A1 (es) | 1987-01-01 |
NZ214088A (en) | 1988-09-29 |
EP0182533A2 (en) | 1986-05-28 |
IE852822L (en) | 1986-05-13 |
AU574532B2 (en) | 1988-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK333788D0 (da) | Farmaceutisk praeparat til behandling af oedelagt bruskvaev | |
DK99086A (da) | Farmaceutiske praeparater til behandling af hukommelsesforstyrrelser | |
PT87133A (pt) | Method of purification of leukaemia inhibitory factor (lif) and of pharmaceutical compounds containing polypeptides with activity of the lif | |
DK170187A (da) | Pharmaceutisk fordelagtigt salt af amlodipin og farmaceutiske praeparater indeholdende dette | |
BR8403186A (pt) | Lamina aperfeicoada de relha | |
DK51493D0 (da) | Laegemiddel indeholdende humant interleukin-1alfa og anvendelse af interleukin-1alfa til fremstilling af et saadant laegemiddel | |
DK164547C (da) | Imidazoliumsalte til brug ved saenkning af blodsukkerniveauet hos pattedyr og farmaceutiske praeparater indeholdende saadanne salte | |
DK127588A (da) | Beta-aminoethylsubstituerede phenylforbindelser, farmaceutiske praeparater indeholdende samme og fremgangsmaader til fremstilling af saadanne forbindelser | |
DK226488D0 (da) | Anvendelse af ace-inhibitorer til fremstilling af farmaceutiske praeparater | |
DK253688A (da) | Laegemiddel til brug ved behandling af atherosclerose | |
DK712388A (da) | Heterocyclisk substituerede oxo- eller thiophthalazinyl-eddikesyre-forbindelser og farmaceutiske praeparater indeholdende disse | |
DK425287A (da) | Fremstilling af et farmaceutisk praeparat til behandling af kongestivt hjertesvigt | |
DK4487D0 (da) | Heterocycliske forbindelser og farmaceutiske praeparater indeholdende disse | |
NO854227L (no) | Fralands plattformkonstruksjon av armert betong og fremgangsmaate ved fremstilling av samme. | |
DK93385A (da) | 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazoliner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser | |
DK240984A (da) | 5-(4-chlor-3-sulfamoylbenzoyl)-2,3-dihydro-2-benzofurancarboxylsyrer, fremgangsmaader til deres fremstilling samt farmaceutiske praeparater indeholdende disse | |
DK369088D0 (da) | Fremgangsmaade til fremstilling af nukleinsyrederivater og fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende disse | |
DK438186D0 (da) | Fremgangsmaade til fremstilling af ved oxygenet beskyttede glycosylfluorider | |
DK701588D0 (da) | N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater | |
DK489084A (da) | Fremgangsmaade til udvinding af beta-elemonsyre og farmaceutisk praeparat indeholdende beta-elemonsyre | |
DK365087A (da) | 1,3,5-trithianderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse | |
DK213988A (da) | Dihydropyridinforbindelser samt medisinsk anvendelse af disse og beslaegtede forbindelser og farmaceutiske praeparater indholdende disse. | |
DK328087A (da) | N-imidazolylmethyl-diphenylazomethiner samt fremgangsmaade til fremstilling af saadanne forbindelser og anvendelse af disse i farmaceutiske praeparater | |
DK670588A (da) | Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet | |
DK151964C (da) | Beta-carbolin-3-carboxylsyrederivater og fremgangsmaade til fremstilling af samme samt farmaceutisk praeparat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |